All Type of News
Extended-release tablets to treat schizophrenia approved by KFDAThe Korea Food and Drug Administration has approved Invega (paliperidone) extended-release tablets, a new atypical antipsychotic, for the treatment of schizophrenia, a spokesper...
|
KFDA approves first Alzheimer's skin patch
The Korea Food and Drug Administration has approved Exelon (rivastigmine) Patch, the first skin patch for the treatment of mild to moderate Alzheimer's disease and Parkinson's disease dementia, according to Novartis K...
Wholesalers speeding up M&A moves
Domestic wholesalers have been speeding up their M&A moves as part of their efforts to beef up competitiveness.
Industry analysts have interpreted the change of business structures via mergers and acquisitions betw...
Yuyu to appeal Fosamax Plus case to patent court
Yuyu Pharm plans to file its lawsuit against MSD Korea to confirm the patent claims of Fosamax Plus in a patent court, after the Korean Intellectual Property Tribunal decided to reject Yuyu's claim that Fosamax Plus i...
Korea's homegrown new drug gets approval in ChinaIlyang Pharm has received marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Chinese drug regulatory agency (SFDA).
The ulcerant market ...
|
Customers utilize pharmacy for purchasing first-aid medicines
The majority of customers prefer pharmacy for purchasing first-aid medicines, such as digestives and cold remedies, to supermarkets, due to good counseling by pharmacists, according to data released in the recent symp...
More curriculums for clinical pharmacology training program should be established
The curriculums for clinical pharmacology training program need to be strengthened up to 50 percent in a would-be pharmacy college pharmacy, said a local professor.
In a local seminar organized by the Korean Colleg...
FTA will hurt pharmaceutical sector
Korea's first generic makers could lose up to 300 billion won if a U.S.-Korea free trade agreement (FTA) goes through, according to pharmaceutical business sources.
The estimated losses are based on an assumption t...
Kangwon Province beckons pharmaceutical firms seeking new investment
Investors' highlight incentives, tax breaks and a friendly atmosphere are Kangwon Province's winning points for pharmaceutical firms who seek new investment.
The province is making active efforts to expand its exis...
SK Chemicals, NCPC signs co-development of recombinant based albuminSK Chemicals said on December 13 that it has signed a contract with North China Pharmaceutical Group Corporation (NCPC), a state-owned and the largest chemic pharmaceutical ente...
|
